nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—CYP3A4—bone cancer	0.963	1	CbGaD
Indacaterol—Chronic obstructive pulmonary disease—Methotrexate—bone cancer	0.00185	0.0504	CcSEcCtD
Indacaterol—Rhinorrhoea—Cisplatin—bone cancer	0.00119	0.0324	CcSEcCtD
Indacaterol—Infection—Carboplatin—bone cancer	0.00117	0.0317	CcSEcCtD
Indacaterol—Hypokalaemia—Cisplatin—bone cancer	0.000638	0.0173	CcSEcCtD
Indacaterol—Nasopharyngitis—Cisplatin—bone cancer	0.000627	0.017	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—bone cancer	0.000502	0.0136	CcSEcCtD
Indacaterol—Connective tissue disorder—Cisplatin—bone cancer	0.000476	0.0129	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—bone cancer	0.000464	0.0126	CcSEcCtD
Indacaterol—Cardiac disorder—Cisplatin—bone cancer	0.00045	0.0122	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—bone cancer	0.000442	0.012	CcSEcCtD
Indacaterol—Immune system disorder—Cisplatin—bone cancer	0.000438	0.0119	CcSEcCtD
Indacaterol—Mediastinal disorder—Cisplatin—bone cancer	0.000437	0.0119	CcSEcCtD
Indacaterol—Malnutrition—Cisplatin—bone cancer	0.000422	0.0115	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—bone cancer	0.000414	0.0112	CcSEcCtD
Indacaterol—Muscle spasms—Cisplatin—bone cancer	0.000406	0.011	CcSEcCtD
Indacaterol—Tremor—Cisplatin—bone cancer	0.000395	0.0107	CcSEcCtD
Indacaterol—Anaemia—Cisplatin—bone cancer	0.00039	0.0106	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—bone cancer	0.000383	0.0104	CcSEcCtD
Indacaterol—Myalgia—Cisplatin—bone cancer	0.000359	0.00976	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000357	0.00969	CcSEcCtD
Indacaterol—Infection—Cisplatin—bone cancer	0.000342	0.0093	CcSEcCtD
Indacaterol—Nervous system disorder—Cisplatin—bone cancer	0.000338	0.00918	CcSEcCtD
Indacaterol—Tachycardia—Cisplatin—bone cancer	0.000336	0.00913	CcSEcCtD
Indacaterol—Skin disorder—Cisplatin—bone cancer	0.000335	0.00909	CcSEcCtD
Indacaterol—Asthma—Methotrexate—bone cancer	0.000332	0.00903	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—bone cancer	0.000328	0.0089	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—bone cancer	0.000322	0.00874	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000314	0.00853	CcSEcCtD
Indacaterol—Asthma—Epirubicin—bone cancer	0.000311	0.00845	CcSEcCtD
Indacaterol—Paraesthesia—Cisplatin—bone cancer	0.000309	0.0084	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—bone cancer	0.000309	0.00839	CcSEcCtD
Indacaterol—Dyspnoea—Cisplatin—bone cancer	0.000307	0.00834	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—bone cancer	0.000303	0.00823	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—bone cancer	0.000303	0.00823	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—bone cancer	0.000298	0.0081	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—bone cancer	0.000298	0.00809	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cisplatin—bone cancer	0.000297	0.00808	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—bone cancer	0.000296	0.00805	CcSEcCtD
Indacaterol—Infestation—Methotrexate—bone cancer	0.000296	0.00805	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—bone cancer	0.000289	0.00785	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—bone cancer	0.000288	0.00782	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—bone cancer	0.000281	0.00762	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—bone cancer	0.00028	0.00762	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—bone cancer	0.000279	0.00758	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—bone cancer	0.000277	0.00754	CcSEcCtD
Indacaterol—Infestation—Epirubicin—bone cancer	0.000277	0.00754	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000267	0.00727	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—bone cancer	0.00026	0.00707	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—bone cancer	0.00026	0.00705	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—bone cancer	0.000258	0.00701	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—bone cancer	0.000257	0.00697	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—bone cancer	0.000257	0.00697	CcSEcCtD
Indacaterol—Hypersensitivity—Cisplatin—bone cancer	0.000254	0.00689	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—bone cancer	0.000247	0.00671	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—bone cancer	0.000245	0.00666	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—bone cancer	0.000245	0.00665	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—bone cancer	0.000241	0.00654	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—bone cancer	0.00024	0.00653	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—bone cancer	0.00024	0.00651	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—bone cancer	0.000232	0.00629	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—bone cancer	0.000231	0.00628	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—bone cancer	0.000227	0.00617	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—bone cancer	0.000226	0.00615	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—bone cancer	0.000225	0.00611	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—bone cancer	0.000224	0.0061	CcSEcCtD
Indacaterol—Rash—Cisplatin—bone cancer	0.000217	0.0059	CcSEcCtD
Indacaterol—Dermatitis—Cisplatin—bone cancer	0.000217	0.0059	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—bone cancer	0.000217	0.00589	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—bone cancer	0.000214	0.00582	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—bone cancer	0.000214	0.00581	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—bone cancer	0.000208	0.00566	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—bone cancer	0.000208	0.00565	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—bone cancer	0.000208	0.00565	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—bone cancer	0.000208	0.00564	CcSEcCtD
Indacaterol—Nausea—Cisplatin—bone cancer	0.000205	0.00556	CcSEcCtD
Indacaterol—Cough—Methotrexate—bone cancer	0.000202	0.00549	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—bone cancer	0.000201	0.00545	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—bone cancer	0.0002	0.00544	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—bone cancer	0.000197	0.00536	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—bone cancer	0.000197	0.00536	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000196	0.00532	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—bone cancer	0.000195	0.00529	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—bone cancer	0.000193	0.00524	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—bone cancer	0.000192	0.0052	CcSEcCtD
Indacaterol—Cough—Epirubicin—bone cancer	0.000189	0.00514	CcSEcCtD
Indacaterol—Infection—Methotrexate—bone cancer	0.000188	0.0051	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—bone cancer	0.000185	0.00504	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—bone cancer	0.000185	0.00504	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—bone cancer	0.000185	0.00501	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—bone cancer	0.000185	0.00501	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—bone cancer	0.000184	0.00499	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000183	0.00498	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—bone cancer	0.00018	0.0049	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—bone cancer	0.00018	0.0049	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—bone cancer	0.000177	0.00481	CcSEcCtD
Indacaterol—Infection—Epirubicin—bone cancer	0.000176	0.00477	CcSEcCtD
Indacaterol—Cough—Doxorubicin—bone cancer	0.000175	0.00475	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—bone cancer	0.000173	0.00471	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—bone cancer	0.000173	0.00469	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000172	0.00468	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—bone cancer	0.000172	0.00467	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—bone cancer	0.000171	0.00464	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—bone cancer	0.000171	0.00464	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—bone cancer	0.00017	0.00461	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00017	0.00461	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—bone cancer	0.000169	0.00458	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—bone cancer	0.000167	0.00454	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000163	0.00443	CcSEcCtD
Indacaterol—Infection—Doxorubicin—bone cancer	0.000163	0.00442	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000161	0.00438	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—bone cancer	0.000161	0.00436	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—bone cancer	0.00016	0.00434	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—bone cancer	0.000159	0.00432	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—bone cancer	0.000159	0.00432	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—bone cancer	0.000158	0.00428	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—bone cancer	0.000153	0.00415	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000149	0.00405	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—bone cancer	0.000147	0.00399	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—bone cancer	0.000146	0.00396	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000141	0.00384	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—bone cancer	0.000139	0.00378	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—bone cancer	0.000134	0.00363	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—bone cancer	0.00013	0.00354	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—bone cancer	0.000125	0.0034	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—bone cancer	0.000125	0.0034	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—bone cancer	0.000121	0.00328	CcSEcCtD
Indacaterol—Rash—Methotrexate—bone cancer	0.000119	0.00324	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—bone cancer	0.000119	0.00323	CcSEcCtD
Indacaterol—Headache—Methotrexate—bone cancer	0.000118	0.00322	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—bone cancer	0.000117	0.00318	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—bone cancer	0.000116	0.00315	CcSEcCtD
Indacaterol—Nausea—Methotrexate—bone cancer	0.000112	0.00305	CcSEcCtD
Indacaterol—Rash—Epirubicin—bone cancer	0.000112	0.00303	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—bone cancer	0.000111	0.00303	CcSEcCtD
Indacaterol—Headache—Epirubicin—bone cancer	0.000111	0.00301	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—bone cancer	0.000108	0.00294	CcSEcCtD
Indacaterol—Nausea—Epirubicin—bone cancer	0.000105	0.00285	CcSEcCtD
Indacaterol—Rash—Doxorubicin—bone cancer	0.000103	0.0028	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—bone cancer	0.000103	0.0028	CcSEcCtD
Indacaterol—Headache—Doxorubicin—bone cancer	0.000103	0.00279	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—bone cancer	9.72e-05	0.00264	CcSEcCtD
